Department of Otolaryngology, Head and Neck Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Department of Biostatistics, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Laryngoscope. 2022 Aug;132(8):1582-1587. doi: 10.1002/lary.29970. Epub 2021 Dec 6.
OBJECTIVES/HYPOTHESIS: Postoperative complications may depend on the systemic inflammatory response. We evaluated the predictive potential of the combination of platelet count and neutrophil-to-lymphocyte ratio (COP-NLR) for the incidence of pharyngocutaneous fistula (PCF) in patients who have undergone total laryngectomy.
Retrospective cohort study.
Patients who underwent total laryngectomy between 2000 and 2020 were recruited from four hospitals. The correlations between the incidence of PCF and several risk factors, including the COP-NLR, were examined. Patients with both elevated platelet count and elevated neutrophil-to-lymphocyte ratio (NLR) were categorized as COP-NLR 2, and patients with either one or no abnormal values of both parameters were assigned as COP-NLR 1 and COP-NLR 0, respectively.
A total of 235 patients were identified. The overall incidence of PCF was 12.3%. The cut-off value for NLR before surgery was set at 3.95 (sensitivity = 58.6%, specificity = 69.4%, area under the curve [AUC] = 0.635), and the platelet count was set at 320 × 10 /L (sensitivity = 27.6%, specificity = 87.9%, AUC = 0.571). Multivariate analysis revealed that COP-NLR was an independent risk factor for PCF (COP-NLR 1 vs. COP-NLR 0: odds ratio [OR], 4.17; 95% confidence interval [CI], 1.64 to 10.59; and COP-NLR 2 vs. COP-NLR 0: OR, 5.33; 95% CI, 1.38 to 20.56).
COP-NLR is a novel predictive factor for the development of PCF in patients undergoing total laryngectomy.
4 Laryngoscope, 132:1582-1587, 2022.
目的/假设:术后并发症可能取决于全身炎症反应。我们评估了血小板计数与中性粒细胞与淋巴细胞比值(COP-NLR)联合对接受全喉切除术患者咽瘘(PCF)发生率的预测潜力。
回顾性队列研究。
本研究招募了 2000 年至 2020 年间在四家医院接受全喉切除术的患者。检查了 PCF 发生率与包括 COP-NLR 在内的几种危险因素之间的相关性。血小板计数和中性粒细胞与淋巴细胞比值(NLR)均升高的患者被归类为 COP-NLR 2,只有一项或两项参数值异常的患者分别被归类为 COP-NLR 1 和 COP-NLR 0。
共纳入 235 例患者。PCF 的总发生率为 12.3%。术前 NLR 的截断值设定为 3.95(灵敏度=58.6%,特异性=69.4%,曲线下面积 [AUC] = 0.635),血小板计数设定为 320×10/L(灵敏度=27.6%,特异性=87.9%,AUC=0.571)。多变量分析显示,COP-NLR 是 PCF 的独立危险因素(COP-NLR 1 与 COP-NLR 0:比值比 [OR],4.17;95%置信区间 [CI],1.64 至 10.59;和 COP-NLR 2 与 COP-NLR 0:OR,5.33;95% CI,1.38 至 20.56)。
COP-NLR 是预测接受全喉切除术患者发生 PCF 的新的预测因素。
4 级喉镜检查,132:1582-1587,2022 年。